Inventor
VESSELS JEFFREY
US13 patents
⚠️ This page may combine multiple inventors who share the name “VESSELS JEFFREY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOGEN MA INC
8 patentsUS12275728B2Apr 15, 2025
O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors
BIOGEN MA INC0 citations60
US12180205B2Dec 31, 2024
O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors
BIOGEN MA INC0 citations60
US12565504B2Mar 3, 2026
Spirocyclic O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors
BIOGEN MA INC0 citations50
US12522595B2Jan 13, 2026
Bicyclic ether O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors
BIOGEN MA INC0 citations50
US12421224B2Sep 23, 2025
Azetidinyl O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors
BIOGEN MA INC0 citations50
US12319679B2Jun 3, 2025
Morpholinyl, piperazinyl, oxazepanyl and diazepanyl O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors
BIOGEN MA INC0 citations50
US11459324B2Oct 4, 2022
O-glycoprotein-2-acetamido-2-deoxy-3-D-glycopyranosidase inhibitors
BIOGEN MA INC0 citations50
US11427561B2Aug 30, 2022
IRAK4 inhibiting agents
BIOGEN MA INC0 citations49
MILLENNIUM PHARM INC
3 patentsUS8802657B2Aug 12, 2014
Compounds useful as Raf kinase inhibitors
MILLENNIUM PHARM INC4 citations82
US7968536B2Jun 28, 2011
Heterocyclic compounds useful as RAF kinase inhibitors
MILLENNIUM PHARM INC9 citations82
US9920048B2Mar 20, 2018
Substituted pyrimidines for inhibiting Raf kinase activity
MILLENNIUM PHARM INC0 citations50